EXEL Competitors & Alternatives
Compare Exelixis Inc with similar stocks in the same industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
EXEL
Main Stock$42.02
Tradestie Score
62
Market Cap
$11.09B
P/E Ratio
15.4
Revenue Growth
0.1%
Analyst Upside
+11.5%
Top Competitors
170 stocks in BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$350.41
|
$160.70B | 24.8 | 58 | Compare |
|
GILD
Gilead Sciences Inc
|
$135.78
|
$137.92B | 20.2 | 57 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$699.75
|
$46.96B | 35.4 | 56 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$85.53
|
$24.57B | - | 49 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$188.62
|
$22.61B | 21.7 | 62 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$129.31
|
$13.59B | 28.3 | 62 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$48.73
|
$10.74B | - | 59 | Compare |
|
QGEN
QIAGEN N.V.
|
$39.33
|
$10.04B | 19.5 | 50 | Compare |
|
TECH
Bio-Techne Corp.
|
$51.82
|
$9.33B | 99.4 | 55 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$61.98
|
$8.77B | 24.7 | 62 | Compare |
More EXEL Analysis
Data updated: Mar 30, 2026 | Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (SIC 2836)
170 stocks in this industry